• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戈谢病的眼科表现。

Ophthalmological findings in Gaucher disease.

机构信息

Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.

National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

出版信息

Mol Genet Metab. 2019 May;127(1):23-27. doi: 10.1016/j.ymgme.2019.02.002. Epub 2019 Feb 15.

DOI:10.1016/j.ymgme.2019.02.002
PMID:31047801
Abstract

Gaucher disease is an autosomal recessive lysosomal storage disorder caused by mutations in the gene GBA1, which encodes the lysosomal protein glucocerebrosidase. Patients with Gaucher disease generally have a variety of clinical manifestations ranging from visceral to neurological involvement and some develop ocular involvement. The most commonly affected organs include the spleen, liver, and bone. Moreover, patients often have hepatosplenomegaly, thrombocytopenia, anemia, and bone involvement related to deficient glucocerebrosidase and the subsequent accumulation of glucosylceramide and glucosylsphingosine in cells. A subset of patients develops neurological manifestations, including seizures, myoclonic epilepsy, and progressive neurodegeneration. Eye involvement tends to be less common and presents with diverse clinical findings. These rare and variable ocular manifestations, involving the vitreous, retina, cornea, uvea, conjunctiva and eye movements, can pose a diagnostic challenge for clinicians, especially those not familiar with the disorder. In this review, we explore the different ophthalmologic findings reported in patients with Gaucher disease, aiming to facilitate diagnosis and expedite treatment for patients presenting with ocular manifestations of this rare disorder.

摘要

戈谢病是一种常染色体隐性溶酶体贮积症,由 GBA1 基因突变引起,该基因编码溶酶体蛋白葡萄糖脑苷脂酶。戈谢病患者通常有多种临床表现,从内脏到神经受累,有些患者还会出现眼部受累。最常受累的器官包括脾脏、肝脏和骨骼。此外,患者常伴有肝脾肿大、血小板减少、贫血和与葡萄糖脑苷脂酶缺乏及随后葡萄糖鞘氨醇和葡萄糖神经酰胺在细胞内蓄积相关的骨骼受累。一部分患者会出现神经表现,包括癫痫发作、肌阵挛性癫痫和进行性神经退行性变。眼部受累往往较少见,表现出多种不同的临床表现。这些罕见和多变的眼部表现涉及玻璃体、视网膜、角膜、葡萄膜、结膜和眼球运动,可能对不熟悉该病的临床医生构成诊断挑战。在这篇综述中,我们探讨了戈谢病患者报告的不同眼科表现,旨在为出现这种罕见疾病眼部表现的患者提供更方便的诊断和更迅速的治疗。

相似文献

1
Ophthalmological findings in Gaucher disease.戈谢病的眼科表现。
Mol Genet Metab. 2019 May;127(1):23-27. doi: 10.1016/j.ymgme.2019.02.002. Epub 2019 Feb 15.
2
Ophthalmic manifestations of Gaucher disease: the most common lysosomal storage disorder.戈谢病的眼部表现:最常见的溶酶体贮积症。
Br J Ophthalmol. 2019 Mar;103(3):315-326. doi: 10.1136/bjophthalmol-2018-312846. Epub 2019 Jan 5.
3
Two cases of neuronopathic form of Gaucher disease - diagnostic difficulties.戈谢氏病神经元病变型 2 例——诊断困难。
Acta Biochim Pol. 2021 Dec 14;69(1):119-122. doi: 10.18388/abp.2020_5760.
4
[Gaucher disease: A review].[戈谢病:综述]
Rev Med Interne. 2019 May;40(5):313-322. doi: 10.1016/j.revmed.2018.11.012. Epub 2019 Jan 11.
5
Exploring genetic modifiers of Gaucher disease: The next horizon.探索戈谢病的遗传修饰因子:下一个前沿。
Hum Mutat. 2018 Dec;39(12):1739-1751. doi: 10.1002/humu.23611. Epub 2018 Sep 11.
6
Gaucher disease: a diagnostic challenge for internists.戈谢病:内科医生面临的诊断挑战。
Eur J Intern Med. 2014 Feb;25(2):117-24. doi: 10.1016/j.ejim.2013.09.006. Epub 2013 Oct 1.
7
A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease.一种新的葡糖脑苷脂酶缺乏的神经元细胞模型为探究戈谢病的病理生理学和治疗方法提供了一种工具。
Dis Model Mech. 2016 Jul 1;9(7):769-78. doi: 10.1242/dmm.024588. Epub 2016 May 19.
8
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.戈谢病的病理生理学、临床表现及治疗综述
Int J Mol Sci. 2017 Feb 17;18(2):441. doi: 10.3390/ijms18020441.
9
The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy.尽管进行了长期的葡萄糖脑苷脂酶替代治疗,3型戈谢病仍出现新发现的眼内病变。
Ups J Med Sci. 2016 Aug;121(3):192-5. doi: 10.3109/03009734.2016.1158756. Epub 2016 Apr 11.
10
The role of neurogenetics in Gaucher disease.神经遗传学在戈谢病中的作用。
Arch Neurol. 1993 Nov;50(11):1212-24. doi: 10.1001/archneur.1993.00540110088009.

引用本文的文献

1
Vitreous opacities and retinal deposits in Gaucher disease type I.I型戈谢病的玻璃体混浊和视网膜沉积物
Eye (Lond). 2025 Feb;39(Suppl 1):15-16. doi: 10.1038/s41433-024-03509-z. Epub 2024 Dec 10.
2
Hepatomegaly and Splenomegaly: An Approach to the Diagnosis of Lysosomal Storage Diseases.肝脾肿大:溶酶体贮积病的诊断方法
J Clin Med. 2024 Mar 2;13(5):1465. doi: 10.3390/jcm13051465.
3
Gaucher Disease: An Unusual Cause of Knee Pain.戈谢氏病:膝关节痛的一个不常见病因。
J Am Acad Orthop Surg Glob Res Rev. 2022 Oct 11;6(10). doi: 10.5435/JAAOSGlobal-D-21-00243. eCollection 2022 Oct 1.
4
Clinical and biochemical footprints of inherited metabolic disorders. VII. Ocular phenotypes.遗传性代谢疾病的临床和生化特征。VII. 眼部表型。
Mol Genet Metab. 2022 Apr;135(4):311-319. doi: 10.1016/j.ymgme.2022.02.002. Epub 2022 Feb 15.
5
Rare Diseases of the Orbit.眼眶部罕见病
Laryngorhinootologie. 2021 Apr;100(S 01):S1-S79. doi: 10.1055/a-1384-4641. Epub 2021 Apr 30.
6
Ocular phenotypes in a mouse model of impaired glucocerebrosidase activity.葡萄糖脑苷脂酶活性缺陷小鼠模型的眼部表型。
Sci Rep. 2021 Mar 16;11(1):6079. doi: 10.1038/s41598-021-85528-4.
7
Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.诊断神经病变型戈谢病:戈谢表型分类的新考虑因素和新挑战。
Mol Genet Metab. 2021 Feb;132(2):49-58. doi: 10.1016/j.ymgme.2021.01.002. Epub 2021 Jan 9.
8
Eye involvement in inherited metabolic disorders.遗传性代谢疾病中的眼部受累情况。
Ther Adv Ophthalmol. 2020 Dec 29;12:2515841420979109. doi: 10.1177/2515841420979109. eCollection 2020 Jan-Dec.